Microbot Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	6.7	3.11	2.47	2.44	13.49	19.65
Short-Term Investments	73.45	2.36	3.92	5.76	2	5
Cash & Short-Term Investments	80.16	5.47	6.39	8.21	15.49	24.65
Cash Growth	1747.81%	-14.33%	-22.18%	-47.04%	-37.15%	-21.23%
Other Current Assets	0.63	0.35	1.54	0.61	0.39	0.61
Total Current Assets	80.79	5.82	7.92	8.81	15.88	25.25
Net Property, Plant & Equipment	0.98	0.21	0.41	0.72	0.89	1.03
Total Assets	81.76	6.03	8.33	9.54	16.77	26.28
Accounts Payable	0.51	0.17	0.36	0.12	0.28	0.28
Accrued Expenses	2.13	2.23	1.03	1.67	1.43	0.88
Current Portion of Leases	0.3	0.07	0.19	0.28	0.28	0.19
Other Current Liabilities	-	-	2.21	-	-	-
Total Current Liabilities	2.93	2.46	3.79	2.07	1.98	1.35
Long-Term Leases	0.6	0.04	0.04	0.18	0.4	0.63
Total Long-Term Liabilities	0.6	0.04	0.04	0.18	0.4	0.63
Total Liabilities	3.54	2.5	3.83	2.25	2.39	1.97
Common Stock	0.66	0.2	0.12	0.08	0.07	0.07
Additional Paid-in Capital	178.19	94.28	83.88	75.97	69.9	68.52
Retained Earnings	-100.62	-90.94	-79.5	-68.76	-55.59	-44.28
Shareholders' Equity	78.22	3.53	4.5	7.29	14.38	24.31
Total Liabilities & Equity	81.76	6.03	8.33	9.54	16.77	26.28
Total Debt	0.9	0.11	0.23	0.46	0.68	0.81
Net Cash (Debt)	79.26	5.36	6.15	7.74	14.81	23.84
Net Cash Growth	1378.99%	-12.92%	-20.52%	-47.73%	-37.86%	-21.57%
Net Cash Per Share	-	-	0.60	1.07	-	-
Book Value	78.22	3.53	4.5	7.29	14.38	24.31
Book Value Per Share	-	-	0.44	1.00	-	-
Tangible Book Value	78.22	3.53	4.5	7.29	14.38	24.31
Tangible Book Value Per Share	-	-	0.44	1.00	-	-

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q